Gossamer Bio, Inc.

GOSS

$0.16

Name : Gossamer Bio, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $78,215,472.00

EPSttm : -0.79

Gossamer Bio, Inc.

$0.16

3.38%

$0.0056

GOSS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

20.93

Margin Of Safety %

Put/Call OI Ratio

0.1

EPS Next Q Diff

0.11

EPS Last/This Y

0.29

EPS This/Next Y

0.36

Price

0.15

Target Price

4.46

Analyst Recom

2.71

Performance Q

-68.45

Upside

-17,381.3%

Beta

2.06

Ticker: GOSS

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	GOSS	0.3356	0.15	0.40	75341
2026-05-12	GOSS	0.3409	0.15	0.25	75394
2026-05-13	GOSS	0.3506	0.15	1.04	75284
2026-05-14	GOSS	0.3309	0.15	0.64	75282
2026-05-15	GOSS	0.3394	0.15	0.43	75286
2026-05-18	GOSS	0.1926	0.15	0.04	54097
2026-05-19	GOSS	0.1991	0.13	0.06	53738
2026-05-20	GOSS	0.2132	0.13	0.08	56053
2026-05-21	GOSS	0.201	0.12	0.01	57592
2026-05-22	GOSS	0.2115	0.12	1.32	57892
2026-05-26	GOSS	0.2177	0.10	0.19	58343
2026-05-27	GOSS	0.2186	0.10	0.06	58747
2026-05-28	GOSS	0.2109	0.10	0.27	59986
2026-05-29	GOSS	0.222	0.10	0.13	60158
2026-06-02	GOSS	0.2002	0.10	2.06	60375
2026-06-03	GOSS	0.1882	0.10	0.06	60733
2026-06-04	GOSS	0.1781	0.10	0.14	60851
2026-06-05	GOSS	0.1747	0.10	0.11	61105
2026-06-08	GOSS	0.1662	0.10	0.19	61009
2026-06-09	GOSS	0.1554	0.10	0.09	61157
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	GOSS	0.33	-6.2	154.8	-0.49
2026-05-12	GOSS	0.34	-6.2	154.8	-0.49
2026-05-13	GOSS	0.35	-6.2	154.7	-0.49
2026-05-14	GOSS	0.33	-6.2	154.9	-0.49
2026-05-15	GOSS	0.34	-6.2	154.8	-0.47
2026-05-18	GOSS	0.19	-6.2	155.9	-0.47
2026-05-19	GOSS	0.20	-6.2	154.7	-0.47
2026-05-20	GOSS	0.22	-6.2	-	-0.47
2026-05-21	GOSS	0.20	-6.2	-	-0.47
2026-05-22	GOSS	0.21	22.2	-	-0.46
2026-05-26	GOSS	0.22	22.2	-	-0.46
2026-05-27	GOSS	0.22	22.2	-	-0.46
2026-05-28	GOSS	0.21	22.2	-	-0.46
2026-05-29	GOSS	0.22	22.2	-	-0.46
2026-06-01	GOSS	0.20	22.2	-	-0.46
2026-06-02	GOSS	0.20	22.2	-	-0.46
2026-06-03	GOSS	0.19	22.2	-	-0.46
2026-06-04	GOSS	0.18	22.2	-	-0.46
2026-06-05	GOSS	0.17	22.2	-	-0.46
2026-06-08	GOSS	0.17	22.2	-	-0.46
2026-06-09	GOSS	0.15	22.2	-	-0.46
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	GOSS	0.00	-3.63	19.57
2026-05-12	GOSS	0.00	-3.63	19.49
2026-05-13	GOSS	0.00	-3.63	19.49
2026-05-14	GOSS	0.00	-3.63	19.49
2026-05-15	GOSS	0.00	-3.63	19.49
2026-05-18	GOSS	0.00	-2.09	19.49
2026-05-19	GOSS	0.00	-2.09	19.49
2026-05-20	GOSS	0.00	-2.09	19.49
2026-05-21	GOSS	0.00	-2.09	20.51
2026-05-22	GOSS	0.00	-2.09	20.51
2026-05-26	GOSS	0.00	-6.81	20.51
2026-05-27	GOSS	0.00	-6.81	20.51
2026-05-28	GOSS	0.00	-6.81	20.93
2026-05-29	GOSS	0.00	-6.81	20.93
2026-06-02	GOSS	0.00	-7.33	20.93
2026-06-03	GOSS	0.00	-7.33	20.93
2026-06-04	GOSS	0.00	-7.33	20.93
2026-06-05	GOSS	0.00	-7.33	20.93
2026-06-08	GOSS	0.00	-7.32	20.93
2026-06-09	GOSS	0.00	-7.32	20.93
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

-0.13

Avg. EPS Est. Next Quarter

-0.09

Insider Transactions

Institutional Transactions

-7.32

Beta

2.06

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-98.9

Target Price

4.46

P/E

Forward P/E

PEG

P/S

0.68

P/B

P/Free Cash Flow

EPS

-0.79

Average EPS Est. Cur. Y

-0.46

EPS Next Y. (Est.)

-0.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-324.82

Relative Volume

1.23

Return on Equity vs Sector %

84.2

Return on Equity vs Industry %

100.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

◆ GOSS Healthcare

$0.16

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

4/20

Pullback

7/25

Volume

4/15

Valuation

12/20

TP/AR

0/10

Options

6/10

RSI

Range 1M

0.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

15/30

Estimates

0/20

Inst/Vol

2/15

Options

9/10

EPS Yr

41.1%

EPS NY

75.6%

52W%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +2687.5% upside

Quality

7/30

Valuation

16/30

Growth

14/25

Stability

6/10

LT Trend

1/5

Upside

+2687.5%

Quality

Gossamer Bio, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 161

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

GOSS

Latest News

—

Caricamento notizie per GOSS…

stock quote shares GOSS – Gossamer Bio Inc. Stock Price stock today

news today GOSS – Gossamer Bio Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch GOSS – Gossamer Bio Inc. yahoo finance google finance

stock history GOSS – Gossamer Bio Inc. invest stock market

stock prices GOSS premarket after hours

ticker GOSS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: GOSS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y